| Contingent Synergistic interactions between non-coding RNAs and DNA-modifying enzymes in myelodysplastic syndromes A Symeonidis, T Chatzilygeroudi, V Chondrou, A Sgourou International Journal of Molecular Sciences 23 (24), 16069, 2022 | 5 | 2022 |
| Genome-wide analysis toward the epigenetic aetiology of myelodysplastic syndrome disease progression and pharmacoepigenomic basis of hypomethylating agents drug treatment response S Siamoglou, R Boers, M Koromina, J Boers, A Tsironi, T Chatzilygeroudi, ... Human Genomics 17 (1), 37, 2023 | 3 | 2023 |
| Fetal hemoglobin induction in azacytidine responders enlightens methylation patterns related to blast clearance in higher-risk MDS and CMML T Chatzilygeroudi, V Chondrou, R Boers, S Siamoglou, ... Clinical Epigenetics 16 (1), 79, 2024 | | 2024 |
| Acute Erythroid Leukemia: From Molecular Biology to Clinical Outcomes P Fernandes, N Waldron, T Chatzilygeroudi, NS Naji, T Karantanos International Journal of Molecular Sciences 25 (11), 6256, 2024 | | 2024 |
| Implementation of advanced analytical methods MeD-seq and LC-MS/MS for assessing the epigenetic profile of high-risk myelodysplastic syndrome T Nikolopoulos, E Bochalis, T Chatzilygeroudi, V Chondrou, I Dereki, ... | | 2024 |
| Real-Life Multicenter Experience of Venetoclax in Combination with Hypomethylating Agents in Previously Untreated Adult Patients with Acute Myeloid Leukemia in Greece T Chatzilygeroudi, I Darmani, N El Gkotmi, P Vryttia, S Douna, A Bouchla, ... Journal of Clinical Medicine 13 (2), 584, 2024 | | 2024 |
| Methylation Patterns of Fetal Hemoglobin Regulating Genes in High-Risk (HR)-MDS Patients Following Treatment with Azacytidine T Chatzilygeroudi, V Chondrou, K Athanasopoulou, S Alexis, E Verigou, ... Blood 142, 6452, 2023 | | 2023 |
| P1606: PRIMARY AND SECONDARY IMMUNE THROMBOCYTOPENIA (ITP) IN ADULTS: REAL WORLD COMPARATIVE RETROSPECTIVE STUDY FROM THE ITP REGISTRY OF THE HELLENIC SOCIETY OF HEMATOLOGY E Stavroulaki, C Pontikoglou, T Chatzilygeroudi, A Kouraklis-Symeonidis, ... HemaSphere 7 (S3), e30004e3, 2023 | | 2023 |
| Topic: AS04-MDS Biology and Pathogenesis/AS04h-Immune deregulation/inflammation: AZACYTIDINE TREATMENT UNDERSCORES ITS HYPOMETHYLATING EFFECT IN HUMAN LEYKOCYTE ANTIGEN G (HLA … T Chatzilygeroudi, V Chondrou, K Athanasopoulou, S Alexis, A Sgourou, ... Leukemia Research 128, 107216, 2023 | | 2023 |
| P1646: PRIMARY IMMUNE THROMBOCYTOPENIA (ITP) IN PATIENTS OLDER THAN 75 YEARS: REAL WORLD DATA FROM THE ITP REGISTRY OF THE HELLENIC SOCIETY OF HEMATOLOGY C Pontikoglou, A Matheakakis, E Stavroulaki, T Chatzilygeroudi, ... HemaSphere 6, 1527-1528, 2022 | | 2022 |
| PF693 PRIMARY IMMUNE THROMBOCYTOPENIA (ITP) IN THE ELRDELRY AND YOUNGER ADULTS: REAL‐WORLD COMPARATIVE RETROSPECTIVE STUDY FROM THE ITP REGISTRY OF THE HELLENIC SOCIETY OF … C Pontikoglou, V Kaliafentaki, E Stavroulaki, V Tzikoulis, P Kanellou, ... HemaSphere 3, 301, 2019 | | 2019 |
| Disseminated intravascular coagulation: An uncontrolled explosion of coagulation leading to consumptive coagulopathy E Verigou, KC Valera, T Chatzilygeroudi, A Symeonidis | | |
Argiris SymeonidisUniversity of Patras, Greece在 upatras.gr 的电子邮件经过验证
